Skip to content

Meperidine Versus Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae

Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01236651
Enrollment
200
Registered
2010-11-09
Start date
2010-11-30
Completion date
2011-09-30
Last updated
2010-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Meperidine or Drotaverine on Effacement and Dilatation of the Cervix During Labor in Full Term Primigravidae

Brief summary

Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae

Detailed description

Comparison Between Meperidine and Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae Protocol of Thesis Submitted for partial fulfillment of master degree in Obstetrics & Gynecology The aim of this work is to compare and to evaluate the efficacy of drotaverine hydrochloride versus meperidine hydrochloride on the duration of the 1st stage of labor.

Interventions

DRUGMeperidine

administer 100mg meperidine i.v during the 1st stage of labor and calculate the duration of this stage of labor

administer 40mg drotaverine i.v during the 1st stage of labor and calculate the duration of this stage of labor

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Healthy volunteers
Yes

Inclusion criteria

● primigravida. * Singleton pregnancy. * Term gestation i.e, 38-41 weeks. * Sure, reliable dates documented by ultrasound in the 1st half of pregnancy. * Vertex presentation with occipito anterior position. * Efficient uterine contractions at a rate of at least 3 to 4 contractions every 10 minutes, each contraction lasting for at least 40 seconds.

Exclusion criteria

● Abnormal presentation or occipito posterior position. * Multiple pregnancies. * Cephalo-pelvic disproportion. * Cervical surgery in the past or history of cervical injury. * Patients on antihypertensive therapy. * Known hypersensitivity to drotaverine or meperidine. * If any other spasmolytic agent had been used within 48 hours.

Design outcomes

Primary

MeasureTime frameDescription
the duration of the first stage of labor6 monthesthe primary outcome is to evaluate whether meperidine or drotaverine is more effective in shortening the duration of the 1st stage of labor
effect on the duration of the 1st stage of labor6 monthesthe primary outcome is to evaluate whether meperidine or drotaverine is more effective on the duration of the 1st stage of labor

Secondary

MeasureTime frame
effect on pain6 monthes

Countries

Egypt

Contacts

Primary Contactmahmoud mohamed
hegab_2008@yahoo.com0020106981179
Backup ContactM H
hegab_2008@yahoo.com0020114440015

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026